Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Acrivastine
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Acrivastine 8mg capsules
0304010A0AAAAAA
|
Acrivastine | Acrivastine | Respiratory System | 12,118 |
|
Benadryl Allergy Relief 8mg capsules
0304010A0BCAAAA
|
Benadryl (Acrivastine) | Acrivastine | Respiratory System | 1,146 |
|
Benadryl Allergy Relief Plus Decongestant capsules
0304010A0BCABAC
|
Benadryl (Acrivastine) | Acrivastine | Respiratory System | 210 |
|
Pseudoephedrine 60mg / Acrivastine 8mg capsules
0304010A0AAACAC
|
Acrivastine | Acrivastine | Respiratory System | 139 |
|
Allergy Relief 8mg capsules
0304010A0BDAAAA
|
Allergy Relief | Acrivastine | Respiratory System | No data available |
|
Semprex 8mg capsules
0304010A0BBAAAA
|
Semprex | Acrivastine | Respiratory System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.